Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus magnesium sulfate for corticosteroid-resistant acute asthma attack
IRCT20200914048715N1Phase 3Completed
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine and magnesium sulfate in asthma (2 arms). Primary endpoints: Improvement in peak expiratory flow rate and Need for hospitalization. Started Nov 2020; status: completed.
02
Drugs
ketaminemagnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20200914048715N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200914048715N1.